AIM: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

Introduction Angiographic vasospasm (VSP), the narrowing of intracranial arteries, is a
complication of aneurysmal subarachnoid hemorrhage (aSAH) and often results in delayed …

Objective To perform an updated meta-analysis to comprehensively assess the efficacy and
safety of cilostazol in preventing aneurysmal subarachnoid hemorrhage (SAH)-related …

Background The opportunities to treat elderly patients with aneurysmal subarachnoid
hemorrhage (aSAH) are increasing globally, but the outcome remains poor. This study …

OBJECTIVE In this study, the authors sought to define the differences in the incidence of
delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated …

The effect of the intraarterial administration of nimodipine as a rescue measure to treat
delayed vasospasm after aSAH remains understudied; therefore, we evaluated its effect on …

Abstract Recently, the Cerebrovascular and Cardiovascular Disease Control Act was
enacted, for which it was necessary to establish a comprehensive and accurate nationwide …

Background The mean age of actively treated subarachnoid hemorrhage (SAH) patients is
increasing. We aimed to compare outcomes and prognostic factors between older and …

Objectives To examine the national, 6-year trends in in-hospital clinical outcomes of patients
with subarachnoid haemorrhage (SAH) who underwent clip** or coiling and the …

BACKGROUND The main pathological factor of cerebral infarction is atherosclerosis, which
is the pathological process of chronic inflammatory diseases such as vascular smooth …